ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Gene Vector Labs Seek Vector Producers

February 23, 1996

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995